"The Company invites individual and institutional investors, as well as advisors and analysts with an interest in the life sciences sector, to attend live, interactive presentations at VirtualInvestorConferences.com
TORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company”), a commercial-stage international biopharmaceutical company focused on cannabinoid-based medicines, is pleased to announce that Aras Azadian, CEO of Avicanna Inc will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on September 17th, 2026."
Framing: assertive ·
First seen: 2026-09-16 ·
Last seen: 2026-09-16 ·
Spread: 1 articles